These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31961195)
1. Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction. Frydland M; Møller JE; Lindholm MG; Hansen R; Wiberg S; Lerche Helgestad OK; Thomsen JH; Goetze JP; Engstrøm T; Frikke-Schmidt R; Ravn HB; Holmvang L; Jensen LO; Kjaergaard J; Hassager C Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):557-566. PubMed ID: 31961195 [TBL] [Abstract][Full Text] [Related]
2. Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activation. Josiassen J; Frydland M; Holmvang L; Lerche Helgestad OK; Okkels Jensen L; Goetze JP; Eifer Møller J; Hassager C Biomarkers; 2020 Sep; 25(6):506-512. PubMed ID: 32649233 [TBL] [Abstract][Full Text] [Related]
3. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock. Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Frydland M; Møgelvang R; Møller JE; Helgestad OKL; Holmvang L; Mark PD; Jensen LO; Hassager C Shock; 2021 Aug; 56(2):255-259. PubMed ID: 34276039 [TBL] [Abstract][Full Text] [Related]
5. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. O'Donoghue ML; Morrow DA; Cannon CP; Jarolim P; Desai NR; Sherwood MW; Murphy SA; Gerszten RE; Sabatine MS J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207959 [TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002 [TBL] [Abstract][Full Text] [Related]
7. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction. Klein A; Wiberg S; Hassager C; Winther-Jensen M; Frikke-Schmidt R; Bang LE; Lindholm MG; Holmvang L; Moeller-Helgestad O; Ravn HB; Jensen LO; Kjaergaard J; Moeller JE; Frydland M Shock; 2020 Mar; 53(3):299-306. PubMed ID: 31058719 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction. Højagergaard MA; Hassager C; Christensen TE; Bang LE; Gøtze JP; Ostrowski SR; Holmvang L; Frydland M Biomarkers; 2020 Mar; 25(2):137-143. PubMed ID: 31902247 [No Abstract] [Full Text] [Related]
9. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. Tolppanen H; Rivas-Lasarte M; Lassus J; Sadoune M; Gayat E; Pulkki K; Arrigo M; Krastinova E; Sionis A; Parissis J; Spinar J; Januzzi J; Harjola VP; Mebazaa A; Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of procalcitonin in ST-elevation myocardial infarction complicated by cardiogenic shock. Sharma YP; Kasinadhuni G; Santosh K; Parashar NK; Sharma R; Bootla D; Kanabar K; Krishnappa D Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):751-757. PubMed ID: 33444068 [TBL] [Abstract][Full Text] [Related]
11. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients. Obling L; Frydland M; Hansen R; Møller-Helgestad OK; Lindholm MG; Holmvang L; Ravn HB; Wiberg S; Thomsen JH; Jensen LO; Kjærgaard J; Møller JE; Hassager C Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):7-15. PubMed ID: 28452562 [TBL] [Abstract][Full Text] [Related]
12. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock. Frydland M; Ostrowski SR; Møller JE; Hadziselimovic E; Holmvang L; Ravn HB; Jensen LO; Pettersson AS; Kjaergaard J; Lindholm MG; Johansson PI; Hassager C Shock; 2018 Nov; 50(5):538-544. PubMed ID: 29438221 [TBL] [Abstract][Full Text] [Related]
13. Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial. Jarai R; Huber K; Bogaerts K; Sinnaeve PR; Ezekowitz J; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ; Crit Care Med; 2010 Sep; 38(9):1793-801. PubMed ID: 20562693 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction. He PC; Duan CY; Liu YH; Wei XB; Lin SG BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock. Luyt CE; Landivier A; Leprince P; Bernard M; Pavie A; Chastre J; Combes A J Crit Care; 2012 Oct; 27(5):524.e7-14. PubMed ID: 22386227 [TBL] [Abstract][Full Text] [Related]
16. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction. Celebi S; Celebi OO; Cetin S; Cetin HO; Tek M; Gokaslan S; Amasyali B; Berkalp B; Diker E; Aydogdu S Arq Bras Cardiol; 2019 Dec; 113(6):1129-1137. PubMed ID: 31664316 [TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction. Davierwala PM; Leontyev S; Verevkin A; Rastan AJ; Mohr M; Bakhtiary F; Misfeld M; Mohr FW Circulation; 2016 Oct; 134(17):1224-1237. PubMed ID: 27777292 [TBL] [Abstract][Full Text] [Related]
18. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085 [TBL] [Abstract][Full Text] [Related]
19. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study. Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]